Pharmaceutical

Which drugs are most likely to be approved in Stem Cell...

Stem Cell Transplantation disease is an indication for drug development with ove...

Which drugs are most likely to be approved in Non-infec...

Non-infectious Uveitis disease is an indication for drug development with over 1...

Which drugs are most likely to be approved in Choroidal...

Choroidal Disease disease is an indication for drug development with over 40 pip...

CRISPR-based assay could revolutionise diagnosis of NTM...

The CRISPR-based assay significantly accelerates the current diagnostic process,...

Esperion snags US label expansion for cardiovascular di...

Esperion Therapeutics’ Nexletol and Nexlizet are now available for patients with...

AriBio licenses Alzheimer’s pill in China for up to $770m

An unnamed Chinese partner takes on AR1001 in an APAC Alzheimer’s market predict...

Birmingham University to develop lollipop for mouth can...

The University of Birmingham has secured £350,000 in funding to develop a flavou...

Gilead acquires CymaBay Therapeutics for $4.3bn

Gilead Sciences has concluded the acquisition of CymaBay Therapeutics in a trans...

FDA approves J&J’s OPSYNVI for pulmonary arterial hyper...

The US FDA approved Johnson & Johnson's (J&J) OPSYNVI for chronic treatment in a...

Cancer Research UK and CRIS fund lung cancer vaccine re...

Cancer Research UK and the CRIS Cancer Foundation have awarded a £1.7m ($2.1m) g...

Pharmaceutical packaging companies and labelling machines

Download our extensive, free list of the leading pharmaceutical packaging compan...

Novo shells out $1.1bn to buy Cardior to expand cardiov...

Novo Nordisk will pay up to $1.1bn in upfront and milestone-based payments, with...

Elahere secures full approval from FDA for types of ova...

The FDA granted accelerated approval for the drug back in November 2022, and gra...

Ironwood Pharmaceuticals files patent for delayed relea...

Discover Ironwood Pharmaceuticals' innovative patent for delayed release pharmac...

AnGes files patent for crispr-based method for modifyin...

Discover how AnGes Inc. is revolutionizing Parkinson's disease treatment with RN...

Verastem files patent for combination treatment of FAK ...

Discover how Verastem Inc.'s patent combines FAK inhibitors with immunotherapeut...